Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

A novel nonpharmacologic technique to remove entrapped radial sheath
Karuparthi, Poorna Rajasekhar, Gulati, Rajiv , Pancholy, Samir , Karuparthi, Poorna R.

Catheterization and Cardiovascular Interventions | July 9, 2014 | Volume: 85 | Issue: 1 | Pages: No page available

10.1002/ccd.25593 | PMID 25045106 Get It

Radial artery access for performance of coronary and peripheral diagnostic as well as interventional procedures is on the rise. With increasing adoption comes the expected increase in procedural complications. We describe a novel, simple, and effective nonpharmacologic solution for sheath entrapment related to pharmaco‐resistant radial artery spasm. © 2014 Wiley Periodicals, Inc.
Family History as a Risk Factor for Carotid Artery Stenosis
Khaleghi, Mahyar, Isseh, Iyad , Jouni, Hayan, Sohn, Sunghwan , Bailey, Kent R. , Isseh, Iyad N, Kullo, Iftikhar J.

Stroke | July 9, 2014 | Volume: 45 | Issue: 8 | Pages: 2252-2256

10.1161/strokeaha.114.006245 | PMID 25005442 Get It

Background and Purpose— We investigated whether family history of stroke or coronary heart disease (CHD) is associated with presence of carotid artery stenosis (CAS). Methods— The study cohort included 864 patients (72±8 years; 68% men) with CAS and 1698 controls (61±11 years; 55% men) referred for noninvasive vascular testing. CAS was defined as ≥70% stenosis in the internal carotid artery on ultrasound or history of carotid revascularization. Controls did not have CAS or history of cerebrovascular disease or CHD. Family history of stroke and CHD was defined as having ≥1 first-degree relative who had stroke or CHD before age 65 years. Logistic regression analysis was used to evaluate whether family history of stroke or CHD was associated with presence of CAS, independent of conventional risk factors. Results— Family history of stroke and CHD was present more often in patients with CAS than in controls, with a resulting odds ratios (95% confidence interval) of 2.02 (1.61–2.53) and 2.01 (1.70–2.37), respectively. The associations remained significant after adjustment for age, sex, body mass index, smoking, diabetes mellitus, hypertension, and dyslipidemia; odds ratios: 1.41 (1.06–1.90) and 1.69 (1.35–2.10), respectively. A greater number of affected relatives with stroke or CHD was associated with higher odds of CAS; adjusted odds ratios: 1.25 (0.91–1.72) and 1.46 (1.14–1.89) versus 2.65 (1.35–5.40) and 2.13 (1.57–2.90) for patients with 1 and ≥2 affected relatives with stroke and CHD, respectively. Conclusions— Family history of stroke and of CHD were each associated with CAS, suggesting that shared genetic and environmental factors contribute to the risk of CAS.
At the interface of sensory and motor dysfunctions and Alzheimer's disease
Gilmore, Grover C. , Kaye, Jeffrey , Murphy, Claire , Wingfield, Arthur , Bennett, David A. , Boxer, Adam L. , Buchman, Aron S. , Cruickshanks, Karen J., Devanand, Davangere P. , Duffy, Charles J., Gates, George A., Holtzer, Roee , Lin, Frank R. , McKee, Ann C. , Morris, John C. , Petersen, Ronald C. , Silbert, Lisa C. , Struble, Robert G., Trojanowski, John Q. , Verghese, Joe , Xu, Shunbin , Albers, Mark W. , Gall, Christine M. , Granholm, Ann‐Charlotte , Hensch, Takao K. , Hyman, Bradley T. , Wilson, Donald A. , Zhang, Li I. , Bennett, David A. , Morris, John C

Alzheimer's & Dementia | July 8, 2014 | Volume: 11 | Issue: 1 | Pages: 70-98

10.1016/j.jalz.2014.04.514 | PMID 25022540 Get It

Abstract Recent evidence indicates that sensory and motor changes may precede the cognitive symptoms of Alzheimer's disease (AD) by several years and may signify increased risk of developing AD. Traditionally, sensory and motor dysfunctions in aging and AD have been studied separately. To ascertain the evidence supporting the relationship between age‐related changes in sensory and motor systems and the development of AD and to facilitate communication between several disciplines, the National Institute on Aging held an exploratory workshop titled “Sensory and Motor Dysfunctions in Aging and AD.” The scientific sessions of the workshop focused on age‐related and neuropathologic changes in the olfactory, visual, auditory, and motor systems, followed by extensive discussion and hypothesis generation related to the possible links among sensory, cognitive, and motor domains in aging and AD. Based on the data presented and discussed at this workshop, it is clear that sensory and motor regions of the central nervous system are affected by AD pathology and that interventions targeting amelioration of sensory‐motor deficits in AD may enhance patient function as AD progresses.
Evolution of Microscopic Colitis to Giant Cell Colitis Without Significant Intraepithelial Lymphocytosis or Thickened Collagen Plate
Petris, Giovanni De , De Petris, Giovanni, Chen, Longwen

International Journal of Surgical Pathology | July 8, 2014 | Volume: 23 | Issue: 3 | Pages: 225-229

10.1177/1066896914542124 | PMID 25006169 Get It

Microscopic colitis (MC) is an umbrella term that encompasses lymphocytic colitis (LC) and collagenous colitis (CC). Several histological variants of these 2 entities exist; among them is the uncommon giant cell colitis (GCC), in which histiocytic giant cells (GCs) are present in background of CC or LC. We report the case of a 71-year-old woman complaining of watery diarrhea for several years that was diagnosed with CC. At follow-up, she developed giant cell colitis (GCC). Nine years later, a colectomy revealed a form of microscopic colitis in which significant intraepithelial lymphocytosis and collagen plate thickening have disappeared while GCs persisted with diffuse mononuclear cells inflammation of the lamina propria. Thinning of the collagen plate in association with GCs has been described previously. The case contributes the possibility of further evolution of MC into a pure giant cell colitis in which the prototypical manifestations of MC have all but disappeared.
Optum Labs: Building A Novel Node In The Learning Health Care System
Wallace, Paul , Shah, Nilay D. , Dennen, Taylor, Bleicher, Paul A. , Crown, William H.

Health Affairs | July 8, 2014 | Volume: 33 | Issue: 7 | Pages: 1187-1194

10.1377/hlthaff.2014.0038 | PMID 25006145 Get It

Clinical utility of complement biomarkers in the diagnosis and treatment of acute thrombotic microangiopathies
Yui, Jennifer , Holers, V. Michael , Yang, Shangbin, Wu, Haifeng, Cataland, Spero R.

British Journal of Haematology | July 8, 2014 | Volume: 167 | Issue: 5 | Pages: 697-698

10.1111/bjh.13025 | PMID 25040791 Get It

Effect of Multiple Chronic Diseases on Health Care Expenditures in Childhood
Zhong, Wenjun , Finnie, Dawn M., Shah, Nilay D. , Wagie, Amy E., Sauver, Jennifer L. St. , Jacobson, Debra J., Naessens, James M. , St Sauver, Jennifer L, St Sauver, Jennifer L

Journal of Primary Care & Community Health | July 8, 2014 | Volume: 6 | Issue: 1 | Pages: 2-9

10.1177/2150131914540916 | PMID 25001922 Get It

Objectives: To examine multiple chronic conditions and related health care expenditures in children. Methods: Retrospective cohort study of all dependents of Mayo Clinic employees aged 0-17 on Jan 1, 2004 with continuous health benefits coverage for 4 years (N=14,727). Chronic conditions, health care utilization, and associated expenditures were obtained from medical and pharmacy claims. Results: The most prevalent chronic conditions were asthma/chronic obstructive pulmonary disease (12%), allergic rhinitis (11%), and behavior problems (9%). The most costly conditions were congenital anomalies, asthma/chronic obstructive pulmonary disease, and behavior problems ($9602, $4335, and $5378 annual cost per child, respectively). Annual health care expenditures increased substantially with the number of chronic conditions, and a small proportion of children with multiple chronic conditions accounted for a large proportion of health care costs. In addition, those with multiple chronic conditions were more likely to persist in the top 10th percentile spender group in year-to-year spending. Conclusion: Children with multiple chronic conditions accounted for a large proportion of health care expenditures. These children were also likely to persist as high spenders in the 4-year time frame. Further research into effective ways to manage the health care delivery for children with multiple chronic conditions is needed.
Association of Age With Survival in Patients With Metastatic Colorectal Cancer: Analysis From the ARCAD Clinical Trials Program
Renfro, Lindsay A. , Gramont, Aimery de , Meyers, Jeffrey P., Seymour, Michel , Saltz, Leonard B. , Goldberg, Richard M. , Eng, Cathy , Díaz‐Rubio, Eduardo , Hammel, Pascal , Lieu, Christopher H. , Maughan, Tim , Sargent, Daniel J. , Eckhardt, Sabine , Saltz, Leonard , Seymour, Matthew T , Eng, Cathy

Journal of Clinical Oncology | July 8, 2014 | Volume: 32 | Issue: 27 | Pages: 2975-2982

10.1200/jco.2013.54.9329 | PMID 25002720 Get It

Purpose This study addressed whether age is prognostic for overall survival (OS) or progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC). Patients and Methods A total of 20,023 patients from 24 first-line clinical trials in the ARCAD (Aide et Recherche en Cancérologie Digestive) database were analyzed. Primary age effects and interactions with age, sex, performance status (PS), and metastatic site were modeled using Cox proportional hazards stratified by treatment arm within study. Results Of total patients, 3,051 (15%) were age ≤ 50 years. Age was prognostic for both OS (P < .001) and PFS (P < .001), with U-shaped risk (ie, highest risk was evident in youngest and oldest patients). Relative to patients of middle age, the youngest patients experienced 19% (95% CI, 7% to 33%) increased risk of death and 22% (95% CI, 10% to 35%) increased risk of progression. The oldest patients experienced 42% (95% CI, 31% to 54%) increased risk of death and 15% (95% CI, 7% to 24%) increased risk of progression or death. This relationship was more pronounced in the first year of follow-up. Age remained marginally significant for OS (P = .08) when adjusted for PS, sex, and presence of liver, lung, or peritoneal metastases, and age was significant in an adjusted model for PFS (P = .005). The age effect did not differ by site of metastatic disease, year of enrollment, type of therapy received, or biomarker mutational status. Conclusion Younger and older age are associated with poorer OS and PFS among treated patients with mCRC. Younger and older patients may represent higher-risk populations, and additional studies are warranted.
Response to Letters Regarding Article, “Stroke or Transient Ischemic Attack in Patients With Transvenous Pacemaker or Defibrillator and Echocardiographically Detected Patent Foramen Ovale”
Friedman, Paul A. , Noheria, Amit , Ackerman, Michael J. , Asirvatham, Samuel J. , Aakre, Christopher A. , Vaidya, Vaibhav R. , Bdeir, Sami, Slusser, Joshua P. , Hodge, David O. , DeSimone, Christopher V. , DeSimone, Daniel C. , Patel, Nikhil A. , Rabinstein, Alejandro A. , Asirvatham, Samuel J

Circulation | July 7, 2014 | Volume: 130 | Issue: 2 | Pages: No page available

10.1161/circulationaha.114.009351 | PMID 25001630 Get It